WASHINGTON, D.C. 20549


                                   FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


          Date of report (Date of earliest event reported): February 8, 2007

                            Applied DNA Sciences, Inc
               (Exact Name of Registrant as Specified in Charter)

           Nevada                   002-90539                  59-2262718
      (State or Other        (Commission File Number)        (IRS Employer
       Jurisdiction                                       Identification No.)
     of Incorporation)

                       25 Health Sciences Drive, Suite 113
                           Stony Brook, New York 11790
               (Address of Principal Executive Offices) (Zip Code)

              (Registrant's telephone number, including area code)

                                 Not Applicable
          (Former Name or Former Address, if Changed Since Last Report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2 below):

|_|   Written communications pursuant to Rule 425 under the Securities Act
      (17 CFR 230.425)

|_|   Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act
      (17 CFR 240.14a-12)

|_|   Pre-commencement  communications  pursuant  to  Rule  14d-2(b)  under  the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement  communications  pursuant  to  Rule  13e-4(c)  under  the
      Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

      On February 8, 2007, Applied DNA Sciences, Inc. issued a press release to
announce that it has licensed the rights to use PHRI Properties' molecular
beacons technology. A copy of the press release is attached as Exhibit 99.1 to
this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits

      (d)   Exhibits.

      Exhibit 99.1   Press release of Applied DNA Sciences, Inc.,
                     dated February 8, 2007.


      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                       Applied DNA Sciences, Inc.

                                       By: /s/ James A. Hayward
                                       James A. Hayward
                                       Chief Executive Officer

Date: February 9, 2007